欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0414/001
药品名称Gabapentin Thame 50mg/ml Oral Solution
活性成分
    • gabapentin 50.0 mg/ml
剂型Oral solution
上市许可持有人Syri Pharma Limited Floor 0, 1 WML, 1 Windmill Lane, Dublin 2, D02 F206, Ireland.
参考成员国 - 产品名称Malta (MT)
Gabapentin Thame 50mg/ml Oral Solution
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Gabapentin Thame 50mg/ml Oral Solution
许可日期2019/03/04
最近更新日期2024/04/10
药物ATC编码
    • N03AX12 gabapentin
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase